Patent · US Active

Method for modifying microcystins and nodularins

US11124818B2 · kind B2 · utility

0Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 9, 2018
Grant dateSep 21, 2021
Priority date
Expiry dateMay 9, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2500/33
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method is used for producing a modified non-ribosomal peptide, e.g. a modified microcystin and/or modified nodularin (together CA), including the steps of: a) growing a modified non-ribosomal peptide producing cyanobacteria strain in a culture media, h) adding one or more modified substrates, preferably modified amino acids to said culture, and c) inoculating the non-ribosomal peptide, producing strain the presence of said modified substrates. The thus modified non-ribosomal peptide may be used for the therapy of various diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.